Korea S.E.
06:00:00 2024-05-09 pm EDT
5-day change
1st Jan Change
2,315
KRW
-0.86%
-29.85%
+8.69%
Bioleaders Corporation announced that it has received KRW 13 billion in funding from C-Square Asset Management, A One Asset Management Co., Ltd, Bluetech Asset Management Co., Ltd., Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm and other investors
On February 18, 2021, Bioleaders Corporation (KOSDAQ:A142760) closed the transaction.
Bioleaders Corporation announced that it has received KRW 10 billion in funding from Moadata Co., Ltd.
Apr. 14
CI
Bioleaders Corporation announced that it has received KRW 15 billion in funding
Mar. 28
CI
Youngchul Park completed the acquisition of 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation.
Mar. 27
CI
Moadata Co., Ltd. completed the acquisition of 6.95% stake in Bioleaders Corporation from Youngchul Park.
Mar. 27
CI
Bioleaders Corporation announced that it expects to receive KRW 15 billion in funding
Mar. 13
CI
Moadata Co., Ltd. agreed to acquire a 6.95% stake in Bioleaders Corporation from Youngchul Park for KRW 15.3 billion
Mar. 12
CI
Bioleaders Corporation announced that it expects to receive KRW 10 billion in funding from Moadata Co., Ltd.
Mar. 11
CI
Youngchul Park agreed to acquire 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation for KRW 9.3 billion.
Mar. 11
CI
Bioleaders Corporation announced that it has received KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.
Jan. 01
CI
An unknown buyer agreed to acquire 20.25052% stake in Anyone F&C Co., Ltd. from Bioleaders Corporation for KRW9.9 billion.
Dec. 28
CI
Bioleaders Corporation announced that it expects to receive KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.
Dec. 28
CI
Bioleaders Corporation(KOSDAQ:A142760) dropped from S&P Global BMI Index
23-09-18
CI
Bioleaders Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-12
CI
Next Bt Co., Ltd. announced that it has received KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors
21-11-30
CI
Bioleaders Corporation announced that it has received KRW 13 billion in funding from Blash Asset Management Co., Ltd, Tiger Asset Management Discretionary Investment Co., Ltd., and other investors
21-11-30
CI
Bioleaders Corporation announced that it has received KRW 8 billion in funding
21-11-30
CI
Bioleaders Corporation announced that it expects to receive KRW 8 billion in funding from Blash Asset Management Co., Ltd, Tiger Asset Management Discretionary Investment Co., Ltd., and other investors
21-11-28
CI
Bioleaders Corporation announced that it expects to receive KRW 8 billion in funding
21-11-28
CI
Next Bt Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors
21-11-28
CI
Bioleaders Corporation announced that it has received KRW 13 billion in funding from C-Square Asset Management, A One Asset Management Co., Ltd, Bluetech Asset Management Co., Ltd., Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm and other investors
21-02-17
CI
Bioleaders Corporation announced that it has received KRW 10.0000159 billion in funding from Asset One Asset Management
21-02-17
CI
Bioleaders Corporation announced that it expects to receive KRW 13 billion in funding from C-Square Asset Management, A One Asset Management Co., Ltd, Bluetech Asset Management Co., Ltd., Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm and other investors
21-02-15
CI
Bioleaders Corporation announced that it expects to receive KRW 10.0000159 billion in funding from Asset One Asset Management
21-02-08
CI
Bioleaders Corporation announced that it has received KRW 7.1 billion in funding
19-04-25
CI
Bioleaders Corporation announced that it has received KRW 4 billion in funding from Hana Financial Investment Co., Ltd., Meritz Securities Co., Ltd. and another investor
19-03-28
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Moa Life Plus, formerly BL Corp, is a Korea-based company primarily engaged in the research and development of biotechnology and biopharmaceuticals. The Company is engaged in the manufacture and sale of health functional foods and functional cosmetics. In addition, the Company is engaged in the distribution of pharmaceuticals and medical supplies. The Company is engaged in the development of cervical cancer treatment, anticancer drugs and other products.
More about the company
1st Jan change
Capi.
+8.69% 64.54M +32.78% 695B +26.51% 568B -4.46% 361B +19.84% 330B +3.80% 283B +16.87% 239B +8.08% 204B -7.89% 198B +8.24% 168B
Other Pharmaceuticals
Stock Market Equities A142760 Stock
News MOA Life Plus Co. Ltd. Bioleaders Corporation announced that it has received KRW 13 billion in funding from C-Square Asset Management, A One Asset Management Co., Ltd, Bluetech Asset Management Co., Ltd., Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm and other investors
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
MOA LIFE PLUS CO. LTD. 